
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 211914-96-4 |
| Catalog No. | 2A-3180092 |
| Chinese Name | 乙基3-(2-((((4-(N-(甲氧基羰基)氨基甲酰基)苯基)氨基)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-羧酰胺基)丙酸酯(达比加群酯杂质) |
| Molecular Formula | C29H31N7O5 |
| Molecular Weight | 557.60 |
| Storage Condition | 2-8°C, protect from light |
| PubChem ID | 232465009 |
| InChI | InChI=1S/C29H31N7O5/c1-4-41-26(37)14-16-36(24-7-5-6-15-31-24)28(38)20-10-13-23-22(17-20)33-25(35(23)2)18-32-21-11-8-19(9-12-21)27(30)34-29(39)40-3/h5-13,15,17,32H,4,14,16,18H2,1-3H3,(H2,30,34,39) |
| InChI Key | LSZDPEVYMDKXLW-UHFFFAOYSA-N |
| Transport Info | Product name: Ethyl 3-(2-((((4-(N-(methoxycarbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamide)propionate (dabigatran etexilate impurity) |
| Related Products in Analytical Standards | ||
|---|---|---|
| Erlotinib Impurity 20 | 236750-62-2 | 2A-3180082 |
| Topiroxostat Impurity | 2044702-36-3 | 2A-3180083 |
| Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo | 618118-95-9 | 2A-3180086 |
| Solifenacin Impurity 1 | 1353274-25-5 | 2A-3180087 |
| Solifenacin EP Impurity B | 1534326-81-2 | 2A-3180088 |
| Dabigatran Impurity 38 | 1416446-40-6 | 2A-3180093 |
| Atorvastatin Impurity 36 | 1624328-52-4 | 2A-3180095 |
| Minocycline Impurity 9 | 601455-95-2 | 2A-3180099 |
| Mirabegron Impurity 17 | 1684452-84-3 | 2A-3180168 |
| Fasudil Impurity 1 HCl 2 | 166895-76-7 | 2A-3180170 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA